Once-nightly pill treats causes of airway collapse to control obstructive sleep apnea in large clinical trial
A once-nightly oral pill helped control obstructive sleep apnea in a large, Phase III clinical trial presented at the 2026 ATS International Conference. The drug, called AD109, is the first therapy to treat OSA by addressing ...
16 hours ago
0
30









